HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

China Resources Related

840.169

-23.228-2.69%

Number of Gainers:- -

Number of Losers:7

Number of Flat:- -

PE:- -

High:860.966

Open:860.176

Low:832.860

Close:863.397

Volume:132.38M

Turnover:3.02B

Market Cap:439.31B

Float Cap:439.31B

Loading ...

China Resources Building Materials H1 Revenue Falls on Lower Cement and Building Materials Demand

CR Building Materials Technology Reports Interim Loss Amid Revenue Decline

China Resources Building Materials Declares Interim Dividend of HKD 0.014 a Share

China Resources Building Materials Technology Holdings H1 Revenue RMB 8,636 Million

THOMSON REUTERS

China Resources Building Materials Technology Holdings H1 Net Income Attributable RMB -441.2 Million

THOMSON REUTERS

China Resources Pharma Reports Interim Results: Subsidiary Net Profit Dips Nearly 8%

China Resources Pharmaceutical Group - Six-Month Revenue RMB 1.64 Bln, Down 50.97% for Kpc Pharmaceuticals

THOMSON REUTERS

CR Pharma Reports 4.91B Yuan Net Profit for Jiangzhong Unit in First Half, Down 5.92%

China Resources Pharmaceutical - Cr Jiangzhong Proposed to Distribute Cash Dividend of RMB5 for Every 10 Shares

THOMSON REUTERS

China Resources Pharmaceutical Group - H1 2026 Revenue Down 2.03% to RMB 4.20 Bln for Tasly Pharmaceutical

THOMSON REUTERS

China Resources Gas Reports Interim Net Profit Decline at Chongqing Unit

CR Boya Bio-Pharmaceutical, China Resources Pharmaceutical Subsidiary, Posts 77.28% Drop in H1 Net Profit Attributable to Shareholders to RMB 51.19 Million

Morgan Stanley Trims China Resources Beer Target to HK$30, Keeps Overweight Stance

China Resources Beer's Baijiu Business Likely to Only Recover in Longer Term

Canada's Diamond Estates Q1 Revenue Falls on Lower Winery Shipments

Jefferies Adjusts China Resources Beer (Holdings)' Price Target to HK$34.70 From HK$37.70, Keeps at Buy

MT Newswires Live

CR Medical Announces Appointment of New Chief Financial Officer

China Resources Medical - Appoints Yu Changjiu as Chief Financial Officer Effective August 20, 2026

THOMSON REUTERS

China Resources Medical Names Yu Changjiu CFO Effective Aug. 20, 2026

China Resources Pharma Reports 5.66% Net Profit Growth for Subsidiary in H1

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/BK1570/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1570","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1570\",,,,,undefined,":{"symbol":"BK1570","market":"HK","secType":"PLATE","nameCN":"China Resources Related","latestPrice":840.16876,"timestamp":1788250091886,"preClose":863.3969,"halted":0,"volume":132384802,"delay":0,"changeRate":-0.026903,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":-23.228149,"latestTime":"09-01 16:00:00","open":860.17645,"high":860.96606,"low":832.86017,"amount":3024932766.5,"amplitude":0.032553,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1788312600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1788226200000,1788235200000],[1788238800000,1788249600000]],"pbRate":0.66562,"peRate":8.253018,"turnoverRate":0.003943,"increases":0,"decrements":7,"flats":0,"marketCap":439312617984,"floatMarketCap":439307818496},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1570\",,,,,undefined,":{"symbol":"BK1570","high":860.96606,"amplitude":0.032553,"preClose":863.3969,"low":832.86017,"pbRate":"0.66562","latestPrice":840.16876,"volume":132384802,"delay":0,"open":860.17645,"prevYearClose":885.673,"prevWeekClose":911.239,"prevMonthClose":863.397,"prevQuarterClose":842.673,"fiveDayClose":925.05,"twentyDayClose":937.871,"sixtyDayClose":1000.164,"secType":"PLATE","market":"HK","turnoverRate":0.003943,"peRate":8.253018,"marketCap":439312617984,"floatMarketCap":439307818496,"timestamp":1788250091886,"nameCN":"China Resources Related"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1570\",,,,undefined,":{"bkCode":"BK1570","up":0,"down":7,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1570\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2661260650","title":"China Resources Building Materials H1 Revenue Falls on Lower Cement and Building Materials Demand","url":"https://stock-news.laohu8.com/highlight/detail?id=2661260650","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661260650?lang=en_us&edition=fundamental","pubTime":"2026-08-21 19:55","pubTimestamp":1787313341,"startTime":"0","endTime":"0","summary":"China Resources Building Materials H1 revenue falls on lower cement and building materials demandOverviewChina cement and building materials supplier's H1 revenue fell 15% yr/yr amid weaker demandComp","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nL1N44I0C0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1135","BK1601","JHX","BK4011","BK1507","BK1570","SG9999003461.SGD","00127","BK1216","LU0274383008.USD","BK1589","01313","BK1563","BK1594","SG9999002950.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173449447","title":"CR Building Materials Technology Reports Interim Loss Amid Revenue Decline","url":"https://stock-news.laohu8.com/highlight/detail?id=1173449447","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173449447?lang=en_us&edition=fundamental","pubTime":"2026-08-21 19:54","pubTimestamp":1787313258,"startTime":"0","endTime":"0","summary":"CR BLDG MAT TEC (01313) has published its interim results for the six months ended June 30, 2026, revealing a shift to a net loss attributable to shareholders. The company recorded revenue of RMB...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999003461.SGD","01313","BK1589","BK1570","BK1563","BK1507","BK1594","LU0274383008.USD","BK1135","SG9999002950.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661267000","title":"China Resources Building Materials Declares Interim Dividend of HKD 0.014 a Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2661267000","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661267000?lang=en_us&edition=fundamental","pubTime":"2026-08-21 19:44","pubTimestamp":1787312641,"startTime":"0","endTime":"0","summary":"China Resources Building Materials declares interim dividend of HKD 0.014 a shareChina Resources Building Materials Technology declared an interim dividend for FY2026 of HKD 0.014 per share.Shares trade ex-dividend on Sept. 10.Record date set for Sept. 18.Payment date scheduled for Oct. 23.Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China Resources Building Materials Technology Holdings Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange  , on August 21, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nNDL8SwgXx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01313","SG9999002950.SGD","SG9999003461.SGD","BK1570","BK1594","BK1135","BK1589","LU0274383008.USD","BK1507","BK1563"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661267097","title":"China Resources Building Materials Technology Holdings H1 Revenue RMB 8,636 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2661267097","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661267097?lang=en_us&edition=fundamental","pubTime":"2026-08-21 19:42","pubTimestamp":1787312540,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nPLXPJ059R:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1563","01313","BK1570","BK1507","BK1594","BK1589","LU0274383008.USD","BK1135","SG9999003461.SGD","SG9999002950.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661267090","title":"China Resources Building Materials Technology Holdings H1 Net Income Attributable RMB -441.2 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2661267090","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661267090?lang=en_us&edition=fundamental","pubTime":"2026-08-21 19:42","pubTimestamp":1787312540,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nPLXPJ059R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1507","BK1570","BK1594","BK1135","BK1563","LU0274383008.USD","01313","SG9999002950.SGD","SG9999003461.SGD","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152216608","title":"China Resources Pharma Reports Interim Results: Subsidiary Net Profit Dips Nearly 8%","url":"https://stock-news.laohu8.com/highlight/detail?id=1152216608","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152216608?lang=en_us&edition=fundamental","pubTime":"2026-08-21 19:24","pubTimestamp":1787311456,"startTime":"0","endTime":"0","summary":"China Resources Pharmaceutical Group Limited (03320) has disclosed the interim financial results for its subsidiary, China Resources Sanjiu Medical & Pharmaceutical Co., Ltd., covering the first half...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0010","BK0012","BK0060","BK0175","BK0188","BK1191","03320","BK0239","BK0183","BK0185","BK1570","000999","BK0028","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661267569","title":"China Resources Pharmaceutical Group - Six-Month Revenue RMB 1.64 Bln, Down 50.97% for Kpc Pharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=2661267569","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661267569?lang=en_us&edition=fundamental","pubTime":"2026-08-21 19:16","pubTimestamp":1787311007,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nFWN44I0HN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1191","BK0188","BK0028","600422","03320","BK1570","BK0239","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186505435","title":"CR Pharma Reports 4.91B Yuan Net Profit for Jiangzhong Unit in First Half, Down 5.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=1186505435","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186505435?lang=en_us&edition=fundamental","pubTime":"2026-08-21 19:02","pubTimestamp":1787310163,"startTime":"0","endTime":"0","summary":"CHINARES PHARMA (03320) has released the interim results for its subsidiary China Resources Jiangzhong Pharmaceutical Co.,Ltd. covering the six months ended June 30, 2026.The unit posted total...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0028","BK0188","03320","BK0239","BK0175","600750","BK1191","BK1570"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661626862","title":"China Resources Pharmaceutical - Cr Jiangzhong Proposed to Distribute Cash Dividend of RMB5 for Every 10 Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2661626862","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661626862?lang=en_us&edition=fundamental","pubTime":"2026-08-21 18:48","pubTimestamp":1787309330,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nFWN44H1R4:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK0028","BK0188","03320","600750","BK0239","BK1570","BK1191","BK0175"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661262877","title":"China Resources Pharmaceutical Group - H1 2026 Revenue Down 2.03% to RMB 4.20 Bln for Tasly Pharmaceutical","url":"https://stock-news.laohu8.com/highlight/detail?id=2661262877","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661262877?lang=en_us&edition=fundamental","pubTime":"2026-08-21 18:44","pubTimestamp":1787309094,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nFWN44I0ET:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1570","BK0196","BK0239","600535","BK0188","03320","BK0012","BK0028","BK1191","BK0183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113034592","title":"China Resources Gas Reports Interim Net Profit Decline at Chongqing Unit","url":"https://stock-news.laohu8.com/highlight/detail?id=1113034592","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113034592?lang=en_us&edition=fundamental","pubTime":"2026-08-21 17:40","pubTimestamp":1787305217,"startTime":"0","endTime":"0","summary":"China Resources Gas Group Ltd (HK: 01193) announced that its subsidiary Chongqing Gas Group Corporation Ltd posted a net profit attributable to shareholders of RMB 75.04 million for the six months...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01193","IE00BVYPNQ40.USD","BK1566","IE00BVYPNP33.GBP","LU0417516738.SGD","LU0417516902.SGD","LU0348825331.USD","IE00BGHQDM52.EUR","BK1221","LU0348735423.USD","BK0252","BK1570","600917","BK1589","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661265419","title":"CR Boya Bio-Pharmaceutical, China Resources Pharmaceutical Subsidiary, Posts 77.28% Drop in H1 Net Profit Attributable to Shareholders to RMB 51.19 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2661265419","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661265419?lang=en_us&edition=fundamental","pubTime":"2026-08-21 16:52","pubTimestamp":1787302374,"startTime":"0","endTime":"0","summary":"CR Boya Bio-pharmaceutical, China Resources Pharmaceutical subsidiary, posts 77.28% drop in H1 net profit attributable to shareholders to RMB 51.19 millionChina Resources Boya Bio-pharmaceutical, a su","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nNDLcd0MBY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1570","BK0239","BK1191","BK0046","300294","BK0197","03320"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189134175","title":"Morgan Stanley Trims China Resources Beer Target to HK$30, Keeps Overweight Stance","url":"https://stock-news.laohu8.com/highlight/detail?id=1189134175","media":"Stock News","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1189134175?lang=en_us&edition=fundamental","pubTime":"2026-08-21 14:14","pubTimestamp":1787292862,"startTime":"0","endTime":"0","summary":"Morgan Stanley has lowered its target price for China Resources Beer (00291) from HK$35 to HK$30 in its latest research report, while maintaining an \"Overweight\" rating on the stock. The adjustment...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1604","LU1794554557.SGD","IE00B031HY20.USD","BK1521","IE0031814852.USD","BK1583","BK1570","LU0359201612.USD","IE00B543WZ88.USD","EWH","BK1510","IE00BPRC5H50.USD","00291","SG9999006514.SGD","LU0359202008.SGD","IE00B29SXG58.USD","LU1720050803.USD","IE00B0169L03.USD","IE0008369823.USD","LU1023057109.AUD","IE00B5MMRT66.SGD","LU0328353924.USD","CRHKY","BK1589","IE0008368742.USD","LU1769817096.USD","80291","LU1769817179.HKD","LU1328615791.USD","BK1180","BK1578"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661252618","title":"China Resources Beer's Baijiu Business Likely to Only Recover in Longer Term","url":"https://stock-news.laohu8.com/highlight/detail?id=2661252618","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661252618?lang=en_us&edition=fundamental","pubTime":"2026-08-21 13:53","pubTimestamp":1787291580,"startTime":"0","endTime":"0","summary":"0553 GMT - China Resources Beer's baijiu business is likely to only recover in the longer term, after the segment's 1H revenue missed estimates, say China Galaxy International analysts in a note. The brewer said in an analyst briefing it is avoiding direct-to-consumer pushes for baijiu--a Chinese distilled liquor--to ease elevated channel inventory and distributor liquidity constraints, they note. The company is instead introducing a third-party custody or consignment model for its new baijiu stock-keeping units, where it will absorb inventory fluctuation to rebuild channel confidence. CGI cuts its 2026-2028 earnings-per-share estimates by 3.7%-3.8% on a weaker baijiu business and higher-than-expected cost pressure. It trims its target price to 31.30 Hong Kong dollars from HK$33.50. Shares rise 2.3% to HK$21.02.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1578","LU1769817179.HKD","SG9999006514.SGD","IE00B29SXG58.USD","IE00B5MMRT66.SGD","LU1328615791.USD","BK1570","00291","IE00BPRC5H50.USD","LU1769817096.USD","IE00B543WZ88.USD","BK1180","IE0031814852.USD","IE0008369823.USD","IE00B0169L03.USD","LU0359202008.SGD","LU1023057109.AUD","LU0359201612.USD","BK1583","80291","BK1510","LU1720050803.USD","IE00B031HY20.USD","LU1794554557.SGD","CRHKY","LU0328353924.USD","IE0008368742.USD","BK1589","BK1521","BK1604"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661370942","title":"Canada's Diamond Estates Q1 Revenue Falls on Lower Winery Shipments","url":"https://stock-news.laohu8.com/highlight/detail?id=2661370942","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661370942?lang=en_us&edition=fundamental","pubTime":"2026-08-21 05:40","pubTimestamp":1787262037,"startTime":"0","endTime":"0","summary":"Canada's Diamond Estates Q1 revenue falls on lower winery shipmentsOverviewCanada wine and spirits producer's Q1 2027 revenue fell 15% yr/yr on lower winery shipmentsGross margin rose to 61.1% of reve","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nL1N44H122:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1180","IE00B5MMRT66.SGD","CRHKY","LU0328353924.USD","BK1578","LU1794554557.SGD","BK1521","IE0008369823.USD","80291","BK1510","BK1583","BK1604","IE0031814852.USD","LU0359202008.SGD","IE00B0169L03.USD","LU1328615791.USD","IE0008368742.USD","BK1589","LU1769817096.USD","SG9999006514.SGD","IE00B29SXG58.USD","BK1570","IE00B543WZ88.USD","LU0359201612.USD","IE00BPRC5H50.USD","LU1023057109.AUD","LU1769817179.HKD","LU1720050803.USD","00291","IE00B031HY20.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660841932","title":"Jefferies Adjusts China Resources Beer (Holdings)' Price Target to HK$34.70 From HK$37.70, Keeps at Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2660841932","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660841932?lang=en_us&edition=fundamental","pubTime":"2026-08-20 20:29","pubTimestamp":1787228992,"startTime":"0","endTime":"0","summary":"China Resources Beer (Holdings) (HKG:0291) has an average rating of buy and mean price target of HK$32.35, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic r","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00B0169L03.USD","IE0031814852.USD","IE00B5MMRT66.SGD","LU0359201612.USD","00291","SG9999006514.SGD","CRHKY","LU1328615791.USD","BK1570","LU0328353924.USD","BK1589","LU0359202008.SGD","IE0008368742.USD","LU1769817179.HKD","BK1180","BK1578","BK1521","IE00B031HY20.USD","80291","LU1023057109.AUD","LU1720050803.USD","IE00BPRC5H50.USD","LU1769817096.USD","IE0008369823.USD","IE00B543WZ88.USD","IE00B29SXG58.USD","BK1604","LU1794554557.SGD","BK1583","BK1510"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109526332","title":"CR Medical Announces Appointment of New Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=1109526332","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109526332?lang=en_us&edition=fundamental","pubTime":"2026-08-20 19:16","pubTimestamp":1787224584,"startTime":"0","endTime":"0","summary":"CR MEDICAL (01515) has officially announced a significant leadership change, appointing Mr. Yu Changjiu as its new Chief Financial Officer.According to a company filing, Mr. Yu's appointment became...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1209","BK1570","01515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660528622","title":"China Resources Medical - Appoints Yu Changjiu as Chief Financial Officer Effective August 20, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2660528622","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660528622?lang=en_us&edition=fundamental","pubTime":"2026-08-20 19:13","pubTimestamp":1787224430,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nFWN44H0FJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1570","01515","BK1209"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660286736","title":"China Resources Medical Names Yu Changjiu CFO Effective Aug. 20, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2660286736","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660286736?lang=en_us&edition=fundamental","pubTime":"2026-08-20 19:13","pubTimestamp":1787224428,"startTime":"0","endTime":"0","summary":"China Resources Medical names Yu Changjiu CFO effective Aug. 20, 2026China Resources Medical appointed Yu Changjiu as chief financial officer, effective Aug. 20, 2026.Yu is chief financial officer of ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nNDL1t1Vwl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0185","BK0010","BK1570","BK0239","BK1191","01515","BK0188","600062","BK0175","BK0028","03320","BK1209"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131757148","title":"China Resources Pharma Reports 5.66% Net Profit Growth for Subsidiary in H1","url":"https://stock-news.laohu8.com/highlight/detail?id=1131757148","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131757148?lang=en_us&edition=fundamental","pubTime":"2026-08-20 17:26","pubTimestamp":1787217978,"startTime":"0","endTime":"0","summary":"China Resources Pharmaceutical Group Limited (03320) has announced the interim financial results of its subsidiary, Dong-E-E-Jiao Co., Ltd., for the six months ended June 30, 2026.The subsidiary...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0187","000423","BK0028","BK1570","SG9999004220.SGD","BK0239","BK0010","SG9999014674.SGD","BK0183","BK1191","BK0188","BK0196","03320","BK0175"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":5,"totalSize":120,"code":"91000000","status":"200"}]}}